BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15462234)

  • 1. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender.
    Puigdollers E; Domingo-Salvany A; Brugal MT; Torrens M; Alvarós J; Castillo C; Magrí N; Martín S; Vázquez JM
    Subst Use Misuse; 2004 Jul; 39(9):1353-68. PubMed ID: 15462234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting entry of injecting drug users into substance abuse treatment.
    Zule WA; Desmond DP
    Am J Drug Alcohol Abuse; 2000 May; 26(2):247-61. PubMed ID: 10852359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
    Darke S; Ross J; Lynskey M; Teesson M
    Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV risks, gender, and cocaine use among opiate users.
    Joe GW; Simpson DD
    Drug Alcohol Depend; 1995 Jan; 37(1):23-8. PubMed ID: 7882870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV risk behaviors among women in methadone maintenance treatment.
    Grella CE; Anglin D; Annon JJ
    Subst Use Misuse; 1996 Feb; 31(3):277-301. PubMed ID: 8834263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.
    Uhlmann S; Milloy MJ; Ahamad K; Nguyen P; Kerr T; Wood E; Richardson L
    Am J Addict; 2015 Jun; 24(4):368-73. PubMed ID: 25808644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Psychol Addict Behav; 2012 Mar; 26(1):145-50. PubMed ID: 21859169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine use and HIV risk behavior in methadone maintenance patients.
    Bux DA; Lamb RJ; Iguchi MY
    Drug Alcohol Depend; 1995 Jan; 37(1):29-35. PubMed ID: 7882871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users.
    Schütz CG; Rapiti E; Vlahov D; Anthony JC
    Drug Alcohol Depend; 1994 Oct; 36(2):129-38. PubMed ID: 7851280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention in a low-threshold methadone maintenance program.
    Torrens M; Castillo C; Pérez-Solá V
    Drug Alcohol Depend; 1996 May; 41(1):55-9. PubMed ID: 8793310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of heroin dependent patients admitted to a methadone treatment program].
    Sanvisens A; Rivas I; Faure E; Muñoz T; Rubio M; Fuster D; Tor J; Muga R
    Med Clin (Barc); 2014 Jan; 142(2):53-8. PubMed ID: 23337454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
    Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
    Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study.
    Wang PW; Lin HC; Yen CN; Yeh YC; Hsu CY; Chung KS; Chang HC; Wu HC; Yen CF
    Harm Reduct J; 2015 May; 12():13. PubMed ID: 25953093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-efficacy and HIV risk behaviors among heroin users in Taiwan.
    Ko NY; Wang PW; Wu HC; Yen CN; Hsu ST; Yeh YC; Chung KS; Yen CF
    J Stud Alcohol Drugs; 2012 May; 73(3):469-76. PubMed ID: 22456252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of treatment with methadone on utilization of medical care by addicts seropositive for the AIDS virus. Results of a descriptive study, Bayonne, 1996].
    Lafitte C; Bonnal F; Daulouede JP; Tignol J
    Encephale; 1998; 24(3):205-14. PubMed ID: 9696913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.